tiprankstipranks
IRLAB Therapeutics AB Class A (DE:6IRA)
FRANKFURT:6IRA
Germany Market
6IRA
IRLAB Therapeutics AB Class A
RESEARCH TOOLSreports
Want to see DE:6IRA full AI Analyst Report?

IRLAB Therapeutics AB Class A (6IRA) Stock News & Sentiment

1 Followers
IRLAB to Webcast Q1 2026 Results as Parkinson’s Pipeline Advances
Premium
Company Announcements
IRLAB to Webcast Q1 2026 Results as Parkinson’s Pipeline Advances
4d ago
IRLAB Highlights Broad Parkinson’s Pipeline and Validated R&D Strategy in 2025 Annual Report
Premium
Company Announcements
IRLAB Highlights Broad Parkinson’s Pipeline and Validated R&D Strategy in 2025 Annual Report
4d ago
IRLAB strengthens Board with commercialization experts as it advances Parkinson’s pipeline
Premium
Company Announcements
IRLAB strengthens Board with commercialization experts as it advances Parkinson’s pipeline
17d ago
IRLAB to Showcase Expanding Parkinson’s Pipeline at Redeye Healthcare Day 2026
Premium
Company Announcements
IRLAB to Showcase Expanding Parkinson’s Pipeline at Redeye Healthcare Day 2026
25d ago
IRLAB Showcases Parkinson’s Pipeline and AI Discovery Advances at AD/PD 2026
Premium
Company Announcements
IRLAB Showcases Parkinson’s Pipeline and AI Discovery Advances at AD/PD 2026
2M ago
IRLAB to Showcase Parkinson’s Pipeline at Gothenburg Life Science Day
Premium
Company Announcements
IRLAB to Showcase Parkinson’s Pipeline at Gothenburg Life Science Day
2M ago
IRLAB Triggers USD 3 Million Milestone as First Patient Dosed in IRL757 Parkinson’s Apathy Trial
Premium
Company Announcements
IRLAB Triggers USD 3 Million Milestone as First Patient Dosed in IRL757 Parkinson’s Apathy Trial
2M ago
More DE:6IRA News >

6IRA News on the Web

IRLAB strengthens Board with commercialization experts as it advances Parkinson’s pipeline
TipRanks News
Bearish
IRLAB partners with Denmark’s Biomia to apply AI-driven ISP platform to CNS drug candidates
TipRanks News
Neutral
IRLAB Therapeutics Appoints New CFO to Strengthen Leadership
TipRanks News
Neutral
IRLAB to Present at Redeye Neurology Event, Expanding Investor Engagement
TipRanks News
Neutral
IRLAB Advances IRL757 for Apathy in Parkinson’s Disease with MSRD Partnership
TipRanks News
Neutral
IRLAB Therapeutics Concludes Trading in Rights Issue Subscription
TipRanks News
Neutral
IRLAB Therapeutics to Present at Aktiedagarna Event in Stockholm
TipRanks News
Neutral
IRLAB Secures Extended US Patent for Mesdopetam
TipRanks News
Neutral

News Score - Last 7 Days

Negative
DE:6IRA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:6IRA’s Media Buzz Sentiment?
1 articles about DE:6IRA were published this week. In an average week, 1 articles are published.
    What is DE:6IRA’s weekly average amount of articles?
    In an average week, 1 articles about DE:6IRA are published.
      What is DE:6IRA’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week